| Florida Family Health Medical Center Pllc | |
|
8389 S Suncoast Blvd Homosassa FL 34446-5028 | |
| (352) 201-3100 | |
| (352) 260-0929 |
| Full Name | Florida Family Health Medical Center Pllc |
|---|---|
| Speciality | Family Medicine |
| Location | 8389 S Suncoast Blvd, Homosassa, Florida |
| Authorized Official Name and Position | Olga M Savage (OWNER) |
| Authorized Official Contact | 3522013100 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Florida Family Health Medical Center Pllc Po Box 111 Homosassa Springs FL 34447-0111 Ph: (352) 201-3100 | Florida Family Health Medical Center Pllc 8389 S Suncoast Blvd Homosassa FL 34446-5028 Ph: (352) 201-3100 |
| NPI Number | 1003176033 |
|---|---|
| Provider Enumeration Date | 05/24/2012 |
| Last Update Date | 07/21/2022 |
| Medicare PECOS PAC ID | 1355505108 |
|---|---|
| Medicare Enrollment ID | O20120607000576 |
News Archive
Viral respiratory infections during the first six months of life are associated with an increased risk for type 1 diabetes. This is the conclusion reached by a team of scientists at the Helmholtz Zentrum München during a study published in the current issue of the renowned US magazine 'JAMA'.
The House Subcommittee for the Federal Workforce, Postal Service, and the District of Columbia heard testimony today on HR 4489, the "FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act." The proposed bill would reform many aspects of how the Federal Employee Health Benefits Program (FEHBP) contracts with pharmacy benefit managers (PBMs) to provide prescription drug benefits to federal workers.
As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.
Medtronic, Inc. today announced the publication of data showing that use of its Reveal family of Insertable Cardiac Monitors led to diagnosis and specific treatment for 78 percent (170 of 218) of patients who experienced a recurrent syncopal (fainting) event during the course of the study.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company, is pleased to announce that the final design specifications of its next-generation dermal injector (RCI-02) have been locked. Prototypes for industrial and regulatory testing will now be built to prepare for an application for CE mark clearance to market the injector in Europe in 2016.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003176033 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Primary |
| Provider Name | Deborah A Lehrich |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1326004490 PECOS PAC ID: 6608886312 Enrollment ID: I20111227000270 |
News Archive
Viral respiratory infections during the first six months of life are associated with an increased risk for type 1 diabetes. This is the conclusion reached by a team of scientists at the Helmholtz Zentrum München during a study published in the current issue of the renowned US magazine 'JAMA'.
The House Subcommittee for the Federal Workforce, Postal Service, and the District of Columbia heard testimony today on HR 4489, the "FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act." The proposed bill would reform many aspects of how the Federal Employee Health Benefits Program (FEHBP) contracts with pharmacy benefit managers (PBMs) to provide prescription drug benefits to federal workers.
As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.
Medtronic, Inc. today announced the publication of data showing that use of its Reveal family of Insertable Cardiac Monitors led to diagnosis and specific treatment for 78 percent (170 of 218) of patients who experienced a recurrent syncopal (fainting) event during the course of the study.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company, is pleased to announce that the final design specifications of its next-generation dermal injector (RCI-02) have been locked. Prototypes for industrial and regulatory testing will now be built to prepare for an application for CE mark clearance to market the injector in Europe in 2016.
› Verified 1 days ago
| Provider Name | Olga Mikhailovna Savage |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1619280450 PECOS PAC ID: 9739343393 Enrollment ID: I20120611000506 |
News Archive
Viral respiratory infections during the first six months of life are associated with an increased risk for type 1 diabetes. This is the conclusion reached by a team of scientists at the Helmholtz Zentrum München during a study published in the current issue of the renowned US magazine 'JAMA'.
The House Subcommittee for the Federal Workforce, Postal Service, and the District of Columbia heard testimony today on HR 4489, the "FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act." The proposed bill would reform many aspects of how the Federal Employee Health Benefits Program (FEHBP) contracts with pharmacy benefit managers (PBMs) to provide prescription drug benefits to federal workers.
As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.
Medtronic, Inc. today announced the publication of data showing that use of its Reveal family of Insertable Cardiac Monitors led to diagnosis and specific treatment for 78 percent (170 of 218) of patients who experienced a recurrent syncopal (fainting) event during the course of the study.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company, is pleased to announce that the final design specifications of its next-generation dermal injector (RCI-02) have been locked. Prototypes for industrial and regulatory testing will now be built to prepare for an application for CE mark clearance to market the injector in Europe in 2016.
› Verified 1 days ago
News Archive
Viral respiratory infections during the first six months of life are associated with an increased risk for type 1 diabetes. This is the conclusion reached by a team of scientists at the Helmholtz Zentrum München during a study published in the current issue of the renowned US magazine 'JAMA'.
The House Subcommittee for the Federal Workforce, Postal Service, and the District of Columbia heard testimony today on HR 4489, the "FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act." The proposed bill would reform many aspects of how the Federal Employee Health Benefits Program (FEHBP) contracts with pharmacy benefit managers (PBMs) to provide prescription drug benefits to federal workers.
As breast density becomes a more recognized risk factor for breast cancer, Royal Philips today announced 510(k) clearance from the U.S. Food and Drug Administration for the Spectral Breast Density Measurement Application for its MicroDose SI full-field digital mammography system. The application is the first spectral Breast Density Measurement tool, meaning adipose (fat) and glandular tissue can be differentiated to accurately measure volumetric breast density.
Medtronic, Inc. today announced the publication of data showing that use of its Reveal family of Insertable Cardiac Monitors led to diagnosis and specific treatment for 78 percent (170 of 218) of patients who experienced a recurrent syncopal (fainting) event during the course of the study.
RepliCel Life Sciences Inc., a clinical stage regenerative medicine company, is pleased to announce that the final design specifications of its next-generation dermal injector (RCI-02) have been locked. Prototypes for industrial and regulatory testing will now be built to prepare for an application for CE mark clearance to market the injector in Europe in 2016.
› Verified 1 days ago
Elaine Christy Ward Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4930 S Suncoast Blvd, Homosassa, FL 34446 Phone: 352-628-7747 Fax: 352-628-0360 | |
Jose A.d. Callueng Md Pa Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8468 W. Periwinkle Lane, Suite C, Homosassa, FL 34446 Phone: 352-628-7270 Fax: 352-628-1620 | |
Citrus Primary Care, Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 7945 S Suncoast Blvd Ste A, Homosassa, FL 34446 Phone: 352-382-1940 Fax: 352-382-1940 | |
Anu R Tatambhotla Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 4049 S Ohio Ave, Homosassa, FL 34446 Phone: 352-628-1000 Fax: 352-628-1120 | |
Homosassa Open Mri Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8464 W Aquaduct St, Homosassa, FL 34448 Phone: 888-273-3445 Fax: 352-628-4801 | |
Sugarmill Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8303 S Suncoast Blvd, Homosassa, FL 34446 Phone: 352-795-6929 Fax: 352-794-5086 |